In this study, we retrospectively analyzed the clinical data of 176 HCC patients and identified IL-41 as a potential marker that negatively correlates with AFP expression using the TCGA the GEO databases and the biobank data of our center. The gene discussed is AFP; the disease is hepatocellular carcinoma.